Best Technology for Cord Blood and Umbilical Cord Banking-MVE

When it comes to cord blood banking, we go all out for quality to safeguard your family’s health. That is why we always insist on the best so that our clients can receive better medical therapy outcome. Unlike other processing and cryopreservation technologies, our carefully selected technology has never been recalled by the manufacturers.

MVE Vapour-Phase Liquid Nitrogen Storage System

  • Reduces cross-contamination
  • Trusted by majority of private cord blood banks worldwide
  • Lowest sample temperature at -190°C

*Cord blood stem cells remain at cryopreservation condition as long as they are stored below Glass Transition Temperature (-135°C)

MVE Vapour-phase Liquid Nitrogen Storage System (MVE)

Storage Media Characteristics
Vapour is a much safer medium than liquid phase to largely reduce the risk of cross-contamination between cord blood units.
Cross-contamination Record
No record.
Majority of private cord blood banks worldwide including Cord Blood Registry and Viacord use vapour freezers only. Client accountability is important for private banks as the cord blood units are legally owned by clients.
Control Difficulty
Design of the vapour freezer's lid allows operator to monitor and arrange cord blood units properly with ease. Clients' unique cord blood samples can be retrieved easily anytime.
Potential of Machine Failure
Zero. MVE system does not rely on electricity to operate.
Recall record

Sepax®2 fully automated cord blood processing technology

  • Trusted by majority of the world’s leading cord blood banks
  • Used by a large number of the public and private cord blood banks worldwide including over 85% of the leading public banks in the NetCord Organization
  • Able to achieve as high as 99.46%^ Total Nucleated Cells (TNC) recovery rate
  • Closed processing system prevents any contamination
  • Fully automated. Processes one cord blood unit at a time to prevent possible cross-contamination
Learn more about Sepax®2
Cell optimaen

Cordlife-Available exclusively in Hong Kong,

Unlike conventional technology that can harvest Mesenchymal stem cells (MSCs) only, Cordlife’s exclusive patented breakthrough technology can isolate and expand not just Mesenchymal Stem Cells (MSCs) but also Epithelial Stem Cells (EpSCs) from your baby’s umbilical cord tissue. With CellOptima™, you can give your family that additional protection coverage that you have always wanted. This technology is only available at Cordlife.
Learn more about CellOptimaTM